ONCY logo

Oncolytics Biotech (ONCY) Cash From Operations

Annual CFO

-$21.07 M
-$3.12 M-17.37%

December 31, 2023


Summary


Performance

ONCY Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherONCYcash flowmetrics:

Quarterly CFO

N/A

September 30, 2024


Summary


Performance

ONCY Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherONCYcash flowmetrics:

TTM CFO

N/A

September 30, 2024


Summary


Performance

ONCY TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherONCYcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ONCY Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-17.4%--
3 y3 years-27.9%--
5 y5 years-129.1%--

ONCY Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-17.8%at low
5 y5-year-40.5%at low
alltimeall time-5757.3%+38.5%

Oncolytics Biotech Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2023
-$21.07 M(+17.4%)
-$4.43 M(-1.9%)
-$21.07 M(-0.8%)
Sep 2023
-
-$4.52 M(-28.5%)
-$21.25 M(+7.5%)
Jun 2023
-
-$6.33 M(+9.3%)
-$19.76 M(+5.1%)
Mar 2023
-
-$5.79 M(+25.4%)
-$18.80 M(+4.8%)
Dec 2022
-$17.95 M(+0.3%)
-$4.61 M(+52.1%)
-$17.95 M(-2.7%)
Sep 2022
-
-$3.03 M(-43.6%)
-$18.45 M(+1.8%)
Jun 2022
-
-$5.37 M(+8.9%)
-$18.13 M(-1.6%)
Mar 2022
-
-$4.93 M(-3.5%)
-$18.43 M(+3.0%)
Dec 2021
-$17.89 M(+8.6%)
-$5.11 M(+88.4%)
-$17.89 M(+5.3%)
Sep 2021
-
-$2.71 M(-52.2%)
-$16.99 M(-11.4%)
Jun 2021
-
-$5.68 M(+29.2%)
-$19.17 M(+7.0%)
Mar 2021
-
-$4.39 M(+4.3%)
-$17.91 M(+8.8%)
Dec 2020
-$16.47 M(+9.8%)
-$4.21 M(-13.9%)
-$16.47 M(-6.8%)
Sep 2020
-
-$4.89 M(+10.7%)
-$17.68 M(+8.5%)
Jun 2020
-
-$4.42 M(+49.8%)
-$16.29 M(+5.7%)
Mar 2020
-
-$2.95 M(-45.6%)
-$15.40 M(+2.7%)
Dec 2019
-$15.00 M(+63.1%)
-$5.42 M(+55.0%)
-$15.00 M(+15.2%)
Sep 2019
-
-$3.50 M(-1.0%)
-$13.02 M(+7.0%)
Jun 2019
-
-$3.53 M(+38.8%)
-$12.16 M(+50.2%)
Mar 2019
-
-$2.55 M(-26.0%)
-$8.09 M(-12.0%)
Dec 2018
-$9.20 M(-19.9%)
-$3.44 M(+30.3%)
-$9.20 M(+15.9%)
Sep 2018
-
-$2.64 M(-594.5%)
-$7.94 M(-4.2%)
Jun 2018
-
$534.30 K(-114.6%)
-$8.29 M(-31.8%)
Mar 2018
-
-$3.65 M(+67.2%)
-$12.16 M(+5.8%)
Dec 2017
-$11.49 M(+21.9%)
-$2.18 M(-27.1%)
-$11.49 M(-4.9%)
Sep 2017
-
-$2.99 M(-10.2%)
-$12.08 M(+6.4%)
Jun 2017
-
-$3.34 M(+11.9%)
-$11.36 M(+11.3%)
Mar 2017
-
-$2.98 M(+7.3%)
-$10.20 M(+8.2%)
Dec 2016
-$9.42 M(-20.0%)
-$2.78 M(+22.5%)
-$9.42 M(-7.9%)
Sep 2016
-
-$2.27 M(+4.0%)
-$10.23 M(+4.8%)
Jun 2016
-
-$2.18 M(-1.1%)
-$9.76 M(-17.0%)
Mar 2016
-
-$2.20 M(-38.5%)
-$11.76 M(-0.1%)
Dec 2015
-$11.78 M(-33.9%)
-$3.58 M(+99.3%)
-$11.78 M(+7.2%)
Sep 2015
-
-$1.80 M(-57.0%)
-$10.99 M(-17.2%)
Jun 2015
-
-$4.18 M(+88.3%)
-$13.27 M(-8.2%)
Mar 2015
-
-$2.22 M(-20.7%)
-$14.45 M(-18.9%)
Dec 2014
-$17.82 M(-24.9%)
-$2.80 M(-31.4%)
-$17.82 M(-8.5%)
Sep 2014
-
-$4.08 M(-23.9%)
-$19.48 M(-9.3%)
Jun 2014
-
-$5.36 M(-4.2%)
-$21.47 M(+2.3%)
Mar 2014
-
-$5.59 M(+25.5%)
-$20.98 M(-11.6%)
Dec 2013
-$23.73 M(-30.7%)
-$4.45 M(-26.6%)
-$23.73 M(-8.4%)
Sep 2013
-
-$6.07 M(+24.6%)
-$25.91 M(-7.4%)
Jun 2013
-
-$4.87 M(-41.7%)
-$27.97 M(-18.0%)
Mar 2013
-
-$8.35 M(+26.0%)
-$34.13 M(-0.4%)
Dec 2012
-$34.27 M(+50.3%)
-$6.63 M(-18.5%)
-$34.27 M(-1.4%)
Sep 2012
-
-$8.13 M(-26.3%)
-$34.76 M(+4.6%)
Jun 2012
-
-$11.02 M(+29.9%)
-$33.25 M(+21.5%)
Mar 2012
-
-$8.49 M(+19.1%)
-$27.37 M(+20.1%)
DateAnnualQuarterlyTTM
Dec 2011
-$22.80 M(+31.5%)
-$7.12 M(+7.7%)
-$22.80 M(+18.0%)
Sep 2011
-
-$6.61 M(+28.5%)
-$19.32 M(+10.8%)
Jun 2011
-
-$5.15 M(+31.7%)
-$17.44 M(+5.7%)
Mar 2011
-
-$3.91 M(+7.1%)
-$16.50 M(-4.8%)
Dec 2010
-$17.33 M(+22.6%)
-$3.65 M(-22.9%)
-$17.33 M(+4.0%)
Sep 2010
-
-$4.73 M(+12.6%)
-$16.66 M(+12.5%)
Jun 2010
-
-$4.20 M(-11.5%)
-$14.81 M(-5.5%)
Mar 2010
-
-$4.75 M(+59.3%)
-$15.67 M(+10.8%)
Dec 2009
-$14.14 M(-1.8%)
-$2.98 M(+3.3%)
-$14.14 M(+4.1%)
Sep 2009
-
-$2.88 M(-43.0%)
-$13.59 M(-12.5%)
Jun 2009
-
-$5.06 M(+57.1%)
-$15.52 M(+6.0%)
Mar 2009
-
-$3.22 M(+32.7%)
-$14.64 M(+1.7%)
Dec 2008
-$14.40 M(+13.4%)
-$2.43 M(-49.6%)
-$14.40 M(+0.8%)
Sep 2008
-
-$4.82 M(+15.3%)
-$14.28 M(+14.6%)
Jun 2008
-
-$4.18 M(+40.4%)
-$12.46 M(-0.1%)
Mar 2008
-
-$2.98 M(+28.7%)
-$12.47 M(-1.8%)
Dec 2007
-$12.69 M(+18.4%)
-$2.31 M(-22.8%)
-$12.69 M(-6.4%)
Sep 2007
-
-$2.99 M(-28.5%)
-$13.56 M(+3.1%)
Jun 2007
-
-$4.19 M(+30.9%)
-$13.15 M(+11.6%)
Mar 2007
-
-$3.20 M(+0.7%)
-$11.78 M(+10.0%)
Dec 2006
-$10.72 M(+17.4%)
-$3.18 M(+22.9%)
-$10.72 M(+9.7%)
Sep 2006
-
-$2.58 M(-8.6%)
-$9.77 M(-4.9%)
Jun 2006
-
-$2.83 M(+32.6%)
-$10.27 M(+6.3%)
Mar 2006
-
-$2.13 M(-4.2%)
-$9.66 M(+5.8%)
Dec 2005
-$9.13 M(+28.5%)
-$2.22 M(-28.0%)
-$9.13 M(+25.0%)
Sep 2005
-
-$3.09 M(+39.5%)
-$7.30 M(+1.8%)
Jun 2005
-
-$2.21 M(+38.3%)
-$7.18 M(-6.1%)
Mar 2005
-
-$1.60 M(+298.1%)
-$7.64 M(+7.6%)
Dec 2004
-$7.10 M(+81.2%)
-$401.90 K(-86.4%)
-$7.10 M(-4.5%)
Sep 2004
-
-$2.96 M(+10.6%)
-$7.44 M(+37.6%)
Jun 2004
-
-$2.68 M(+152.2%)
-$5.40 M(+29.4%)
Mar 2004
-
-$1.06 M(+43.8%)
-$4.18 M(+6.5%)
Dec 2003
-$3.92 M(-15.2%)
-$737.90 K(-20.4%)
-$3.92 M(+5.6%)
Sep 2003
-
-$927.30 K(-36.0%)
-$3.71 M(-35.7%)
Jun 2003
-
-$1.45 M(+80.0%)
-$5.77 M(+53.2%)
Mar 2003
-
-$804.80 K(+51.8%)
-$3.77 M(-18.5%)
Dec 2002
-$4.62 M(+67.5%)
-$530.00 K(-82.3%)
-$4.62 M(-5.9%)
Sep 2002
-
-$2.99 M(-637.9%)
-$4.91 M(+92.2%)
Jun 2002
-
$555.80 K(-133.5%)
-$2.56 M(-30.1%)
Mar 2002
-
-$1.66 M(+102.9%)
-$3.65 M(+32.4%)
Dec 2001
-$2.76 M(+29.8%)
-$817.70 K(+28.9%)
-$2.76 M(+2.0%)
Sep 2001
-
-$634.20 K(+16.9%)
-$2.71 M(-12.0%)
Jun 2001
-
-$542.30 K(-29.2%)
-$3.07 M(+12.7%)
Mar 2001
-
-$765.70 K(+0.2%)
-$2.73 M(+28.2%)
Dec 2000
-$2.13 M(+491.3%)
-$764.20 K(-23.7%)
-$2.13 M(+56.1%)
Sep 2000
-
-$1.00 M(+413.2%)
-$1.36 M(+278.0%)
Jun 2000
-
-$195.30 K(+18.2%)
-$360.50 K(+118.2%)
Mar 2000
-
-$165.20 K
-$165.20 K
Dec 1999
-$359.70 K
-
-

FAQ

  • What is Oncolytics Biotech annual cash flow from operations?
  • What is the all time high annual CFO for Oncolytics Biotech?
  • What is Oncolytics Biotech annual CFO year-on-year change?
  • What is the all time high quarterly CFO for Oncolytics Biotech?
  • What is the all time high TTM CFO for Oncolytics Biotech?

What is Oncolytics Biotech annual cash flow from operations?

The current annual CFO of ONCY is -$21.07 M

What is the all time high annual CFO for Oncolytics Biotech?

Oncolytics Biotech all-time high annual cash flow from operations is -$359.70 K

What is Oncolytics Biotech annual CFO year-on-year change?

Over the past year, ONCY annual cash flow from operations has changed by -$3.12 M (-17.37%)

What is the all time high quarterly CFO for Oncolytics Biotech?

Oncolytics Biotech all-time high quarterly cash flow from operations is $555.80 K

What is the all time high TTM CFO for Oncolytics Biotech?

Oncolytics Biotech all-time high TTM cash flow from operations is -$165.20 K